52nd week of 2015 patent applcation highlights part 21 |
Patent application number | Title | Published |
20150368130 | PROCESS FOR PURIFICATION TREATMENT OF WASTEWATER AND APPARATUS FOR PURIFICATION TREATMENT OF WASTEWATER - A process for purification treatment of wastewater according to the present invention is a process for conducting a purification treatment of wastewater containing polyvinyl alcohol by using a membrane bioreactor process, the process including adding a nutrient to a treatment system. The nutrient is preferably added to an aeration tank. The nutrient preferably contains nitrogen. An amount of the nutrient initially added is preferably 5% or more and 25% or less in terms of nitrogen. The process for purification treatment of wastewater preferably includes a step of measuring a nitrogen content after a treatment, and an amount of the nutrient added is preferably adjusted on the basis of the result of this measurement while checking the effect on the basis of a chemical oxygen demand. The nutrient may be added to the aeration tank by a mechanism that adds the nutrient to the treatment system or by feeding the nutrient manually to the treatment system. | 2015-12-24 |
20150368131 | INTEGRATED SYSTEM OF A METHANOGENIC ANAEROBIC REACTOR AND MEMBRANE BIOREACTOR FOR THE ELIMINATION OF ORGANIC MATERIAL AND NITROGEN FROM WASTEWATER - Integrated methanogenic anaerobic reactor and membrane bioreactor, and method for eliminating organic matter and nitrogen in urban or industrial wastewater, preferably with COD concentrations between 150 and 5000 mg/L and where the eliminations of total nitrogen that occur are between 15 and 50 mg/L, at temperatures above 15° C. The wastewater treatment takes place thanks to three stages of treatment: methanogenic anaerobic stage, anoxic stage with biofilms and suspended biomass and aerobic filtration stage with biofilms and suspended biomass. | 2015-12-24 |
20150368132 | WASTEWATER TREATMENT SYSTEMS AND METHODS - The present invention relates to improved wastewater treatment systems and methods. In one embodiment, the present invention utilizes microbial consortia and the final effluent of the treated wastewater is remarkably clean, and has low levels of hazardous chemicals, unwanted nutrient values and/or total solids. Advantageously, the wastewater treatment system and method of the present invention reduces the use of chemical compounds in the treatment process. Further, valuable biomasses can be produced from the wastewater using the treatment process of the present invention. | 2015-12-24 |
20150368133 | PROCESS FOR TREATING WATERS PRODUCED OR COLLECTED FROM THE OIL EXTRACTION IN MINING OPERATIONS AND REDUCING THE TENDENCY OF CALCIUM SCALING OF PROCESS EQUIPMENT - Oil sands process water (OSPW) is directed to an evaporator that evaporates the OSPW and produces steam and a concentrated brine. The OSPW includes alkalinity and calcium hardness. To inhibit calcium carbonate scaling of the evaporator, magnesium oxide is mixed with the OSPW, resulting in the precipitation of magnesium hydroxide which acts as a seed material for calcium carbonate precipitation to prevent fouling. The process crystallizes the calcium carbonate and the mixture of magnesium hydroxide and calcium carbonate crystals are circulated through the evaporator as well as recirculated to a point upstream of the evaporator. | 2015-12-24 |
20150368134 | Pool Water Purifying Device - A pool water purifying device includes a rough filtration module having a first housing. A rough filter is received in the first housing. An electrolyzing module includes a second housing. Two electrodes and an ultraviolet lamp are mounted to the second housing and extend into the second housing. The electrodes are electrically connected to a power supply. A fine filtration module includes a third housing receiving a fine filter. A piping unit includes a plurality of pipes and a plurality of valves. The valves connect the first, second, and third housings to intercommunicate the first, second, and third housings with each other. The valves are mounted on the pipes to control communication between the pipes. | 2015-12-24 |
20150368135 | PASTEURIZATION SYSTEM WITH PURIFICATION OF THE PROCESS LIQUID - Pasteurization system with purification of the process liquid, with a feed and evacuation conveyor system for containers. At least one treatment zone with sprinkling nozzles to spray the containers with a process liquid such as water, the treatment zone including a screening unit with a sedimentation area for the deposition of sediment from the process liquid, a closed-loop circuit to re-use the process liquid, with devices to remove the sediment from the sedimentation area for each zone and to feed the sediment into a central filter unit. The central filter unit has at least one filter module for the filtration of solid matter from the inputted sediment so that the filtered process liquid is conserved. Devices to return the filtered process liquid to one or several treatment zones are also provided. | 2015-12-24 |
20150368136 | MOBILE PROCESSING SYSTEM FOR HAZARDOUS AND RADIOACTIVE ISOTOPE REMOVAL - A mobile processing system is disclosed for the removal of radioactive contaminants from nuclear process waste water. The system is fully scalable, modular, and portable allowing the system to be fully customizable according the site-specific remediation requirements. It is designed to be both transported and operated from standard sized intermodal containers or custom designed enclosures for increased mobility between sites and on-site, further increasing the speed and ease with which the system may be deployed. Additionally, the system is completely modular wherein the various different modules perform different forms or stages of waste water remediation and may be connected in parallel and/or in series. Depending on the needs of the particular site, one or more different processes may be used. In some embodiments, one or more of the same modules may be used in the same operation. | 2015-12-24 |
20150368137 | METHOD AND APPARATUS FOR TREATING NATURAL GAS AND OIL WELL WASTE WATERS FOR REMOVAL OF CONTAMINANTS AND DISSOLVED SOLIDS - A method for treating wastewater is disclosed. The method is useful in particular for treating wastewater that is generated from the process of drilling, hydraulic fracturing and/or cleaning a bore of an oil or natural gas well bore. The method may include performing cold lime softening of the wastewater to form waste salt floes, filtration of waste salt floes, ozonation of the filtrate from the filtration, and reverse osmosis of the filtrate to produce a purified permeate. | 2015-12-24 |
20150368138 | METHOD AND SYSTEM FOR THE INTEGRAL TREATMENT OF WASTEWATER FROM THE MAIZE INDUSTRY - A novel integral process for the treatment of wastewater, commonly known as nejayote, from the nixtamal, masa and tortilla industry, having an improved method for removing the insoluble fraction and a filtration system for separating and concentrating the fractions forming the nejayote. The method includes the steps of: (a) neutralizing the nejayote; (b) enzymatically hydrolysing the starch granules; (c) flocculating and separating the insoluble fraction. The system includes the steps of (a) microfiltration; (b) ultrafiltration for concentrating long-chain carbohydrates; (c) ultra/nano filtration for concentrating medium-size compounds; (d) nanofiltration/reverse osmosis for concentrating small molecules and obtaining water of sufficient quality that it can be re-used or safely discharged into the environment. In one embodiment of the invention, in order to remove unwanted phenolic compounds, the process includes a method including the steps of: (a) acidifying the effluents at pH<4; (b) flocculating and separating the unwanted insoluble fraction. | 2015-12-24 |
20150368139 | INTEGRAL CAPSULE FOR BLISTER SUPPRESSION IN MOLTEN GLASS - A precious metal structure which has an internal gas permeable membrane is described herein for a glass manufacturing vessel configured to have molten glass flow therein. The internal gas permeable membrane can be supplied with an atmosphere of gas (or gases) to control the flux of hydrogen into our out of the molten glass or otherwise improve the production of the molten glass. In this manner, the undesirable detrimental reactions that can occur at the interface of the molten glass and precious metal interface which can cause defects in the molten glass such as bubbles or solid inclusions can be stopped or at least substantially reduced. | 2015-12-24 |
20150368140 | METHOD OF MANUFACTURING GLASS PLATE HAVING CURVED SURFACE SHAPE, AND GLASS PLATE HAVING A CURVED SURFACE SHAPE - Provided is a method that can manufacture a glass plate having a curved surface shape with high surface accuracy even without polishing the surface after forming and a glass plate manufactured by the method. The method of manufacturing a glass plate having a curved surface shape includes the steps of: preparing an original glass plate, a forming die ( | 2015-12-24 |
20150368141 | LAMINATED GLASS STRUCTURE AND METHOD OF MANUFACTURE - Disclosed is a laminated glass structure with one or more inner glass layers with at least one in tension and two outer glass layers in compression wherein one or both of the outer layers at least partially wrap around the one or more inner layers at one or more of the edges of the laminated glass structure. Also disclosed is a process for forming a laminated glass structure, comprising providing a laminated glass structure, removing at least some glass from at least one the edges of the structure to produce a concavity in at the at least one edge and applying heat to the at least one edge. | 2015-12-24 |
20150368142 | SELF GLAZED CERAMIC/GLASS COMPOSITE AND METHOD FOR MANUFACTURING THE SAME - The invention provides a glazed composite manufactured using waste materials, wherein the waste materials are capable of producing ceramic forming oxides, glass modifying oxides and ceramic modifying oxides. The waste materials include ceramic waste and colored glass waste. The invention also provides a method for manufacturing composition of the glazed composite. | 2015-12-24 |
20150368143 | METHOD OF MANUFACTURING AN OPTICAL FIBER - A manufacturing method that enables stably making a high-quality optical fiber is provided. The manufacturing method of the present invention comprises: a softened portion falling step in which an optical fiber preform is heated in a heating furnace and a dropping part of softened portion of the preform thus heat-softened is allowed to drop; and a drawing step for drawing the preform such that the softened glass is drawn into a fiber by applying a tension with a take-up means after the softened portion falling step, whereas the preform is rotated about its axis at the softened portion falling step. | 2015-12-24 |
20150368144 | POLYGONAL TIP PLATE MODULE AND BUSHING ASSEMBLY COMPRISING SUCH MODULES - The present invention concerns a tip plate module for use in a bushing assembly for the production of glass fibres, said tip plate module comprising side walls surrounding at least a portion of the perimeter of a tip plate ( | 2015-12-24 |
20150368145 | GLASS COMPOSITION, GLASS COMPOSITION FOR CHEMICAL STRENGTHENING, STRENGTHENED GLASS ARTICLE, AND COVER GLASS FOR DISPLAY - Provided is a glass composition containing, in mass %: 58 to 64% SiO | 2015-12-24 |
20150368146 | ALUMINOSILICATE GLASSES - Compounds, compositions, articles, devices, and methods for the manufacture of light guide plates and back light units including such light guide plates made from glass. In some embodiments, light guide plates (LGPs) are provided that have similar or superior optical properties to light guide plates made from PMMA and that have exceptional mechanical properties such as rigidity, CTE and dimensional stability in high moisture conditions as compared to PMMA light guide plates. | 2015-12-24 |
20150368147 | FICTIVATED GLASS AND METHOD OF MAKING - Silicate glasses that are fictivated and fast cooled and have high levels of intrinsic or “native” damage resistance. When ion exchanged, the silicate glasses described herein have a Vickers crack initiation threshold of at least 15 kgf and, in some embodiments, at least about 25 kgf. | 2015-12-24 |
20150368148 | GLASSES HAVING NON-FRANGIBLE STRESS PROFILES - A glass exhibiting non-frangible behavior in a region where substantially higher central tension is possible without reaching frangibility is provided. This region allows greater extension of the depth of compression in which fracture-causing flaws are arrested, without rendering the glass frangible despite the presence of high central tension region in the sample. | 2015-12-24 |
20150368149 | TRANSITION METAL-CONTAINING, ION EXCHANGEABLE COLORED GLASSES - Glasses that can be chemically strengthened and are colored by transition metals. Most of the glasses are black, with some having high damage resistance and compressive surface layers having high compressive stress and depth of layer after ion exchange. These colored glasses do not require a post-forming heat treatment to produce color and are formable by fusions drawing, rolling, slot drawing, and float glass processes. | 2015-12-24 |
20150368150 | ION EXCHANGEABLE GLASS WITH HIGH CRACK INITIATION THRESHOLD - Alkali aluminosilicate glasses that are resistant to damage due to sharp impact and capable of fast ion exchange are provided. The glasses comprise at least 4 mol % P | 2015-12-24 |
20150368151 | OPTICAL GLASS, OPTICAL GLASS BLANK, GLASS MATERIAL FOR PRESS MOLDING, OPTICAL ELEMENT, AND METHODS FOR PRODUCING THEM - An aspect of the present invention relates to optical glass, wherein, in a glass composition based on oxides, a content of P | 2015-12-24 |
20150368152 | Low-E Panels and Methods for Forming the Same - Embodiments provided herein describe low-e panels and methods for forming low-e panels. A transparent substrate is provided. A reflective layer is formed above the transparent substrate. A dielectric layer is formed between the transparent substrate and the reflective layer. The dielectric layer includes niobium, tin, and aluminum. | 2015-12-24 |
20150368153 | STRENGTHENED GLASS WITH DEEP DEPTH OF COMPRESSION - Chemically strengthened glass articles having at least one deep compressive layer extending from a surface of the article to a depth of at least about 45 μm within the article are provided. In one embodiment, the compressive stress profile includes a single linear segment extending from the surface to the depth of compression DOC. Alternatively, the compressive stress profile includes two linear portions: the first portion extending from the surface to a relatively shallow depth and having a steep slope; and a second portion extending from the shallow depth to the depth of compression. Methods of achieving such stress profiles are also described. | 2015-12-24 |
20150368154 | Method for the Dry Slaking of Calcium and Magnesium Oxides from Calcomagnesian Compounds - The invention relates to a method for the dry slaking of calcium oxides and magnesium from calcomagnesian compound containing preferably at least 10 wt. % of MgO in relation to the total weight of said calcomagnesian compound, in which calcomagnesian compound is supplied to a slaking vessel, a slaking aqueous phase is supplied to the slaking vessel, followed by slaking the calcomagnesian compound delivered to the slaking vessel, by means of the slaking aqueous phase, and forming hydrated solid particles of calcium hydroxides and magnesium, in the presence of an additive. The invention also relates to the compound produced in this way. | 2015-12-24 |
20150368155 | HIGH CARBON CELLULAR CONCRETE - Implementations described and claimed herein provide a process for creating a high-carbon cellular concrete that may include high-carbon ash, cement, water, and surfactants to produce a high-carbon cellular concrete. The high-carbon cellular concrete wet mix maintains its cellular properties while it is placed and cures. Also, because of the gelling characteristics and viscosity of the cellular concrete wet mix, it may be placed in a manner that requires fewer lifts or stages in a placement, which may reduce time and expense. Further, the cellular concrete wet mix may travel laterally during placement without losing its cellular matrix of micro-bubbles before curing. | 2015-12-24 |
20150368156 | UTILIZATION OF HEAVY OIL ASH TO PRODUCE SELF-CONSOLIDATED CONCRETE - A heavy oil ash self-compacting concrete can include aggregate, heavy oil ash fines, water, and cement. The heavy oil ash can include more than 90% carbon, by weight. In an embodiment, the heavy oil ash self-compacting concrete can flow under its own weight and yet maintain a stable mixture consistency. | 2015-12-24 |
20150368157 | CALCINER AND A METHOD FOR CALCINATION OF A CARBON DIOXIDE RICH SORBENT - A method for calcination of a carbon dioxide rich sorbent (containing CaCO | 2015-12-24 |
20150368158 | Solution for Forming Insulation Coating and Grain-Oriented Electrical Steel Sheet - A solution for forming an insulation coating of grain-oriented electrical steel sheet includes an aqueous solution prepared by mixing a phosphate solution and colloidal silica. Chromium is not added to the aqueous solution. The colloidal silica includes silica particles surface-modified by an aluminate or is prepared by adding an aluminate to colloidal silica such as conventional colloidal silica. | 2015-12-24 |
20150368159 | MAGNESIA CARBON BRICK - In the present invention, the attempt was made to increase the denseness (to lower the porosity) of a magnesia carbon brick furthermore thereby providing the magnesia carbon brick having a high durability never found in the past. The magnesia carbon brick of the present invention comprises a magnesia raw material and a graphite, wherein the magnesia carbon brick contains the graphite with the amount thereof in the range of 8% or more by mass and 25% or less by mass and the magnesia raw material with the amount thereof in the range of 75% or more by mass and 92% or less by mass, the both amounts being relative to the total amount of the magnesia raw material and the graphite; as a grain size distribution of the magnesia raw material, the magnesia raw material having particle diameter of in the range of 0.075 mm or more and 1 mm or less is blended with the amount thereof being 35% or more by mass relative to the total amount of the magnesia raw material and the graphite, and a mass ratio of the magnesia raw material having the particle diameter of in the range of 0.075 mm or more and 1 mm or less to the magnesia raw material having the particle diameter of less than 0.075 mm is 4.2 or more; and an apparent porosity thereof after firing in reducing atmosphere for 3 hours at 1400° C. is 7.8% or less. | 2015-12-24 |
20150368160 | SINTERED CERAMIC BALL AND METHOD OF MAKING SAME - A sintered ceramic ball is described that includes an incomplete ceramic ball portion with a wall with an exterior surface, the wall having an interior space located radially interior of an inner surface of the wall. The incomplete ceramic ball portion also has an exterior surface, the exterior surface having an exterior surface area. The sintered ceramic ball further includes a ceramic plug joined with the incomplete ceramic ball portion to form a continuous exterior ball surface. The ceramic plug includes an exterior plug surface and a plug wall. The plug surface includes an exterior plug surface area, wherein the exterior plug surface area is between about 5% to 49.9% of the sum of the exterior surface area of the incomplete ceramic ball portion and the exterior plug surface area. The interior space of the sintered ceramic ball is sealed within the wall and the plug wall. | 2015-12-24 |
20150368161 | PIEZOELECTRIC MATERIAL, PIEZOELECTRIC ELEMENT, AND ELECTRONIC EQUIPMENT - There are provided a lead- and potassium-free piezoelectric material that has a high Curie temperature and a high mechanical quality factor and is stable in long-term driving and a piezoelectric element including the lead- and potassium-free piezoelectric material. A piezoelectric material containing a perovskite-type metal oxide having the general formula (1): Na | 2015-12-24 |
20150368162 | PIEZOELECTRIC MATERIAL, PIEZOELECTRIC ELEMENT, AND ELECTRONIC EQUIPMENT - There is provided a lead- and potassium-free piezoelectric material having a high piezoelectric constant and a satisfactory insulation property and a piezoelectric element that includes the piezoelectric material. The piezoelectric material contains a perovskite-type metal oxide having the general formula (1): (Na | 2015-12-24 |
20150368163 | SOL-GEL METHOD FOR PREPARATION OF CERAMIC MATERIAL - A process for producing a ceramic material including providing an aqueous solution comprising at least one transition metal ion and one or more further transition metal ion and/or one or more additional ion; adding to the aqueous solution a quaternary ammonium or phosphonium hydroxide comprising at least one alkyl group containing about 8 or more carbon atoms to form a combined aqueous solution; mixing the combined aqueous solution to form a gel; transferring the formed gel to a furnace; and heating the formed gel to a temperature sufficient for a time sufficient to calcine the gel to form a solid ceramic material. The process in accordance with the present invention provides an improved ceramic material, in some embodiments of which is suitable for use in the cathode material of a lithium ion battery. | 2015-12-24 |
20150368164 | METHOD FOR TREATING GYPSUM - The present invention relates to a method for producing a gypsum-containing foamed prefabricated building material and to a gypsum-containing foamed prefabricated building material. | 2015-12-24 |
20150368165 | Cultivation medium presenting water availability comparable to that of a peat - The present invention provides a cultivation medium characterized in that it is made by defibration of a bark-based composition comprising at least 70% by volume of bark, said cultivation medium having water availability that is greater than or equal to 250 mL/L. | 2015-12-24 |
20150368166 | SYSTEM AND METHOD FOR PRODUCING FERTILZER FROM ORGANIC WASTE - In one aspect, a system for the production of fertilizer from organic waste comprises a microbial digester configured to digest the organic waste, wherein the digestion of the organic waste produces a digestate having a liquids component and a solids component. A spray dryer module is provided for receiving the digestate and reducing moisture content in the digestate to produce a substantially dry fertilizer product. In further aspects, methods and fertilizer compositions are provided. | 2015-12-24 |
20150368167 | PROCESS FOR SEPARATING HYDROCARBON COMPOUNDS - Disclosed herein are processes for producing and separating ethane and ethylene. In some embodiments, an oxidative coupling of methane (OCM) product gas comprising ethane and ethylene is introduced to a separation unit comprising two separators. Within the separation unit, the OCM product gas is separated to provide a C | 2015-12-24 |
20150368168 | OPTIONS TO REDUCE FOULING IN MTO DOWNSTREAM RECOVERY - A process is presented for removing the fouling problems associated with the product recovery in a methanol to olefins conversion process. The process includes passing the quenched MTO process stream to a product separator, wherein an intermediate stream is generated and includes water and heavier hydrocarbons. The intermediate stream is processed to remove the buildup of heavier hydrocarbons. | 2015-12-24 |
20150368169 | PREPARATION OF FLUORINATED OLEFINS VIA CATALYTIC DEHYDROHALOGENATION OF HALOGENATED HYDROCARBONS - A process for making a fluorinated olefin having the step of dehydrochlorinating a hydrochlorofluorocarbon having at least one hydrogen atom and at least one chlorine atom on adjacent carbon atoms, preferably carried out in the presence of a catalyst selected from the group consisting of (i) one or more metal halides, (ii) one or more halogenated metal oxides, (iii) one or more zero-valent metals/metal alloys, (iv) a combination of two or more of the foregoing. | 2015-12-24 |
20150368170 | METHOD FOR MANUFACTURING SUCCINIC ACID ESTERS - The invention pertains to a process for preparing a succinic acid ester comprising the steps of bringing an aqueous liquid comprising succinic acid, alcohol, and at least 5 wt. % of a dissolved chloride salt selected from magnesium chloride, calcium chloride, and zinc chloride, calculated on the weight of the liquid, to reaction conditions, thereby obtaining a succinic acid ester, and recovering the succinic acid ester and an aqueous solution comprising the dissolved chloride salt. It has been found that the process according to the invention shows a high yield and has a high reaction rate. Additionally, it has been found that the process makes it possible to carry out the separation of the succinic acid ester from the aqueous reaction medium in high yield. | 2015-12-24 |
20150368171 | PROCESS FOR PRODUCING POLYOLS - A process for producing polyols (such as neopentyl glycol) is disclosed which comprises reacting formaldehyde and another aldehyde in the presence of a trialkylamine catalyst and a base promoter to form an Aldol condensation reaction product. The base promoter improves removal of nitrogen containing salts prior to hydrogenation of the hydroxy aldehyde to produce the polyol. The improved process also reduces trialkylamine catalyst usage, improves trialkylamine catalyst recovery, and reduces nitrogen-containing salts prior to hydrogenation. | 2015-12-24 |
20150368172 | Method for Producing Alpha, Beta-Unsaturated Alcohol - A method of producing an α,β-unsaturated alcohol at a high conversion ratio and a high selectivity is provided, which comprises continuously supplying a gas mixture containing an α,β-unsaturated aldehyde and at least an equimolar amount of a secondary alcohol using zirconium oxide as a catalyst to thereby produce the corresponding α,β-unsaturated alcohol through a hydrogen transfer reaction from the secondary alcohol. According to this method, crotyl alcohol can be produced at a high yield from crotonaldehyde using isopropanol as a hydrogen source, the crotonaldehyde being obtained by dehydrogenating bioethanol to produce acetaldehyde and then subjecting acetaldehyde to aldol condensation. | 2015-12-24 |
20150368173 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES - The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents. | 2015-12-24 |
20150368174 | NONYL ALCOHOLS WITH A LOW DEGREE OF BRANCHING AND THEIR DERIVATIVES - The invention relates to nonyl alcohols with a low degree of branching and derivatives produced using them. In particular the present invention relates to mixture of primary nonyl alcohols in which at least 80% of the alkyl chains are linear and at least 15% of the alkyl chains are branched at the 2-carbon position and its derivatives. The low degree of branching produces derivatives that are more elongated and less bulky that similar derivatives produced with more highly branched alcohols. | 2015-12-24 |
20150368175 | PRODUCTION OF PARA-PROPYLBENZALDEHYDE - The present invention is a process for preparing a 4-alkylbenzaldehyde (para-alkylbenzaldehyde). An alkylbenzene, solvated in a solvent comprising at least one aliphatic solvent having in the range of 3 to 15 carbons, is reacted with carbon monoxide, in the presence of an aluminum halide and a hydrogen halide acid. Disproportionation is reduced and proportion of para-alkyl-benzaldehyde is increased with respect to other methods. | 2015-12-24 |
20150368176 | METHOD FOR MANUFACTURING CARBOXYLIC ACID - A process and a production apparatus for producing a high-purity carboxylic acid, from which a metal-containing impurity and/or a carbonyl-group-containing impurity have been highly purified, are provided. | 2015-12-24 |
20150368177 | PROCESS FOR PURIFYING (METH)ACRYLIC ACID - A process for producing a grade of (meth)acrylic acid having residual formaldehyde levels of under 100 parts per Million. | 2015-12-24 |
20150368178 | PROCESS FOR THE MANUFACTURE OF ALKYLFLUOROACRYLATE - The invention relates to a process for the manufacture of an alkylfluoroacrylate starting from alkylfluoroacetate and an oxalic acid ester, wherein an alkane liquid under the reaction conditions is applied as the solvent in one of the reaction steps. | 2015-12-24 |
20150368179 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL - The present invention concerns a process for the preparation of a compound of formula | 2015-12-24 |
20150368180 | ACID CATALYZED OLIGOMERIZATION OF ALKYL ESTERS AND CARBOXYLIC ACIDS - The oligomerization of certain carboxylic acids and alkyl esters derived from natural oils is disclosed. This includes the oligomerization of C | 2015-12-24 |
20150368181 | RECYCLABLE CHIRAL CATALYST FOR ASYMMETRIC NITROALDOL REACTION AND PROCESS FOR THE PREPARATION THEREOF - The present invention relates to preparation of highly efficient chiral recyclable homogeneous catalysts generated in situ by the reaction of chiral oligomeric [H | 2015-12-24 |
20150368182 | PREPARATION OF FLUOROSULFONATE ESTERS AND ONIUM SALTS DERIVED THEREFROM - The present invention is directed to methods for preparing a fluorosulfonate ester or a salt thereof, through a reaction of a dissolved sulfonyl fluoride (R | 2015-12-24 |
20150368183 | MANUFACTURING PROCESS FOR MEMANTINE - A method for manufacturing 3,5-dimethyl-1-adamantanamine of the present invention comprises: (i) a step of reacting 3,5-dimethyl-1-adamantanol with an acid and nitrile in an organic solvent to obtain a reaction solution; (ii) a step of adding water to the reaction solution obtained in step (i) to obtain 1-amido-3,5-dimethyladamantane; and (iii) a step of hydrolyzing 1-amido-3,5-dimethyladamantane obtained in step (ii) in the presence of an alcohol-containing solvent and an inorganic base. | 2015-12-24 |
20150368184 | PURIFICATION OF CADAVERINE - One aspect of the invention relates to a method for reducing salt content in an aqueous cadaverine salt composition comprising adjusting the pH of the aqueous cadaverine salt composition to provide a first composition comprising an aqueous cadaverine composition and a solid composition, and removing the solid composition from the first composition to provide the aqueous cadaverine composition. Another aspect of the invention relates to a method for the purification of cadaverine from an aqueous cadaverine salt composition using the salt-reducing method described herein; and obtaining cadaverine from the aqueous cadaverine composition. | 2015-12-24 |
20150368185 | PURIFICATION OF CADAVERINE USING HIGH BOILING POINT SOLVENT - One aspect of the invention relates to a method for the purification of cadaverine from an aqueous cadaverine composition comprising one or more involatile impurities, the method comprising obtaining cadaverine from evaporation or distillation of the aqueous cadaverine composition wherein one or more solvents are added to the evaporation/distillation system before the evaporation/distillation starts, during the evaporation/distillation and/or after the evaporation/distillation substantially stops when no more evaporation/distillation is observed; wherein the one or more solvents comprise at least one or more high boiling point (HBP) solvents. In certain embodiments, cadaverine may be evaporated/distilled at an unexpectedly lower heating temperature for an unexpectedly shorter heating time to provide a desired yield. Because cadaverine may decompose at high temperature, the unexpectedly lower heating temperature and unexpectedly shorter heating time decrease the undesired cadaverine decomposition. The methods disclosed herein provides unexpected high recovery rate (˜100%) in the evaporation/distillation of cadaverine at a larger scale at a lower heating temperature compared to conventional distillation methods. Thus, the method disclosed herein will be highly appreciated in the industrial production of cadaverine. | 2015-12-24 |
20150368186 | LYSINE SPECIFIC DEMETHYLASE-1 INHIBITORS AND THEIR USE - The present invention relates to a compound of Formula 1, wherein: (A) is heteroaryl or aryl; each (A′), if present, is independently chosen from aryl, arylalkoxy, arylalkyl, heterocyclyl, aryloxy, halo, alkoxy, haloalkyl, cycloalkyl, haloalkoxy, and cyano, wherein each (A′) is substituted with 0, 1, 2, or 3 substituents independently chosen from halo, haloalkyl, haloalkoxy, aryl, arylalkoxy, alkyl, alkoxy, amido, —CH | 2015-12-24 |
20150368187 | INHIBITORS OF THE TUMOR NECROSIS FACTOR RECEPTOR COMPLEX - The present invention relates to compounds of formula (I) that are inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions: Formula (I) | 2015-12-24 |
20150368188 | SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AS AGGRECANASE INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS - The present invention relates to compounds of the formula I and in particular medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which ADAMTS5 is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, hepatocirrhosis, traumatic cartilage injuries, pain, allodynia or hyperalgesia. | 2015-12-24 |
20150368189 | PENTENENITRILE ISOMERIZATION - Pentenenitrile oligomers formed in a process for isomerizing cis-2-pentenenitrile to 3-pentenenitrile are minimized in the presence of an aluminium oxide catalyst. The process comprises providing an aluminium oxide catalyst having an alkali metal and/or alkaline earth metal and/or iron content, measured in the form of alkali metal oxide and/or alkaline earth metal oxide and/or iron oxide, respectively of less than 5000 ppm by weight. | 2015-12-24 |
20150368190 | PROCESS FOR SEPARATING AN ISOCYANATE PREPARED BY PHOSGENATION OF A PRIMARY AMINE IN THE GAS PHASE FROM THE GASEOUS CRUDE PRODUCT OF THE PHOSGENATION - The present invention relates to a process for separating an isocyanate prepared by reaction of a primary amine with an excess of phosgene in the gas phase from the gaseous crude product obtained in the reaction, wherein
| 2015-12-24 |
20150368191 | METHOD OF FORMING UREA BY INTEGRATION OF AN AMMONIA PRODUCTION PROCESS IN A UREA PRODUCTION PROCESS AND A SYSTEM THEREFOR - A method of forming urea by integration of an ammonia production process with that of a urea production process, as well as a system for the method is disclosed. Also, an alternative method of forming urea by integration of a part of an ammonia production process with that of a urea production process, as well as a system for the alternative method. | 2015-12-24 |
20150368192 | A METHOD OF SYNTHESIZING CREATINE DERIVATIVES - A method of synthesizing (Boc) | 2015-12-24 |
20150368193 | BIOACTIVE POLYMERS - Polycondensation products of aminoguanidine and/or 1,3-diaminoguanidine with one or more diamines are provided including polyguanidine derivatives of the following formula (I) or a salt thereof: | 2015-12-24 |
20150368194 | System and Method for Fluoralkylated Fluorophthalocyanines with Aggregating Properties and Catalytic Driven Pathway for Oxidizing Thiols - Organo-metallic materials with reduced steric hindrance and the ability to aggregate are disclosed. The metal remains capable of binding additional molecules. As an example, Zn complexes that prove aggregation are provided. Such aggregation may help improve or trigger new surface properties of the materials, alone or in combination with others. In a further implementation of the present disclosure, a robust molecule that resists degradation via nucleophilic, electrophilic and radical attacks is provided. Coordinated O | 2015-12-24 |
20150368195 | INDOLINE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF INFLAMMATION DISEASES - The invention is based on the discovery that 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines and 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles has great potential as a novel agent to be used in the treatment of inflammation-associated diseases, particularly, inflammatory arthritis and fibrosis. | 2015-12-24 |
20150368196 | ANTIVIRAL COMPOUNDS - Compounds useful for treating and preventing viral infections including influenza are disclosed. Methods of treating or preventing viral infections, including influenza A infections are disclosed. Specifically, aminoadamantane derivatives that are structurally analogous to amantadine, including spirocyclic compounds, are provided for the treatment of amantadine-insensitive influenza infection in a subject. | 2015-12-24 |
20150368197 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG - Pharmaceutical compositions and methods are for treatment of an inflammatory disease of the lung caused by inhalation of a toxic agent or an irritant. In one example, chlorine inhalational lung injury can be treated using compounds useful in such compositions. | 2015-12-24 |
20150368198 | N1-Cyclic Amine-N5-Substituted Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same - The present invention provides an N1-cyclic amine-N5-substituted biguanide derivative compound represented by Formula 1, a method of preparing the same and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient. The biguanide derivatives have an effect of inhibiting cancer cell proliferation, cancer metastasis and cancer recurrence by activation of AMPK, even when administered in a small dose compared with conventional drugs. | 2015-12-24 |
20150368199 | PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZE- PINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF, AND COMPOUNDS USEFUL IN THAT PROCESS - The invention concerns a new process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepine-4-yl]-propionic acid methyl ester | 2015-12-24 |
20150368200 | METHOD FOR SYNTHESIZING PIRFENIDONE - A process for synthesizing pirfenidone from bromobenzene having less than about 0.15% by weight dibromobenze is disclosed. Also disclosed are processes of synthesizing pirfenidone without using ethyl acetate or n-butanol, and pirfenidone having controlled levels of ethyl acetate, n-butanol, di(5-methyl-2-pyridinone)benzenes, and other impurities having specified retention times. Also disclosed are formulated dosage forms including the disclosed pirfenidone. | 2015-12-24 |
20150368201 | 2-Aminopyridine-based Selective Neuronal Nitric Oxide Synthase Inhibitors - Aminopyridine compounds, as can be used in conjunction with methods for modulation of nitric oxide synthase activity. | 2015-12-24 |
20150368202 | HYDROXYPYRIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE FOR TREATING INFLAMMATORY, NEURODEGENERATIVE, OR IMMUNE-MEDIATED DISEASES - Provided herein are hydroxypyridone derivatives, for example, a compound of Formula I, and pharmaceutical compositions thereof. Also provided herein are methods for treating, preventing, or ameliorating one or more symptoms of an inflammatory, neurodegenerative, or immune-mediated disease (e.g., multiple sclerosis). | 2015-12-24 |
20150368204 | Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity - The present invention pertains to a compound of formula (I) | 2015-12-24 |
20150368205 | POLY (ADP-RIBOSE) POLYMERASE INHIBITOR - Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like. | 2015-12-24 |
20150368206 | METHODS FOR PREPARATION OF (4,6-DIHALO-PYRIMIDIN-5-YL)-ACETALDEHYDES - This invention relates to the synthesis of chemical compounds and particularly to methods for the preparation of (4,6-dihalo-pyrimidin-5-yl)-acetaldehydes. The methods involve preparing a compound of the following general formula V from a compound of the following general formula IV through hydrolysis under the action of mercury dichloride and calcium carbonate, according to the following equation: | 2015-12-24 |
20150368207 | METHOD FOR TREATING MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS WITH IODO PYRIMIDINE DERIVATIVES - Compounds useful for the inhibition of macrophage migration inhibitory factor (MIF) are provided herein, having the Formula I: | 2015-12-24 |
20150368208 | Substituted N-(3-(Pyrimidin-4-YL)Phenyl)Acrylamide Analogs as Tyrosine Receptor Kinase BTK Inhibitors - In one aspect, the invention relates to substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs, derivatives thereof, and related compounds, which are useful as inhibitors of the BTK kinase; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the BTK kinase. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 2015-12-24 |
20150368209 | 4-Pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (PLK1) for the treatment of cancer and their use for the treatment of bacterial infections - The present invention relates to 4-pyrimidinylamino-benzenesulfonamide derivatives of general formula (I) and pharmaceutically acceptable salts, solvates, hydrates, regioisomeric and polymorphic forms thereof, processes for manufacturing of them, the use of them, as well as pharmaceutical compositions containing at least one of them as pharmaceutically active agent(s) together with pharmaceutically acceptable carrier, excipient and/or diluents, especially for the inhibition of polo-like kinases (PLKs) and the treatment of cancer. Said 4-pyrimidinylamino-benzenesulfonamide compounds have been also identified as new drug candidates for the prevention and/or treatment of infectious diseases like bacterial diseases e.g. tuberculosis, including the currently multidrug-resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB) as well as for preventing tuberculosis. | 2015-12-24 |
20150368210 | 2-AMINOPYRAZINE DERIVATIVES AS CSF-1 R KINASE INHIBITORS - The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, N-oxide, hydrate or solvate thereof: wherein: ring A, R | 2015-12-24 |
20150368211 | RUFINAMIDE AND DERIVATIVES AND THEIR USE IN MODULATING THE GATING PROCESS OF HUMAN VOLTAGE-GATED SODIUM CHANNELS - The present invention provides compounds of formula I or a salt, solvate, or stereoisomer thereof, wherein X is H, or an electron withdrawing group such as a halogen, NH | 2015-12-24 |
20150368212 | UV ABSORBER-CONTAINING URETHANE ACRYLATE - The present invention relates to a UV absorber-comprising urethane acrylate, to a process for its preparation, and to the use thereof. The UV absorber is chemically bonded into the system. The UV absorber-comprising urethane acrylate has the formula (I): | 2015-12-24 |
20150368213 | Novel Inhibitors of System Xc- - The present invention is directed to novel inhibitors of system X | 2015-12-24 |
20150368214 | SCHIFF BASES OF THIAZOLES: A NEW CLASS OF UREASES INHIBITORS - One embodiment of the invention relates to treating diseases associated with increased urease enzyme activity comprising administering an effective amount of a compound selected from a group consisting of 28 thiazoles Schiff bases. Kinetic studies were performed on ten (10) of the most active compounds. | 2015-12-24 |
20150368215 | THERMO-MECHANICALLY INTEGRATED PROCESS FOR THE PRODUCTION OF ETHYLENE OXIDE FROM A FLOW OF ETHANOL - Dehydrating an ethanol feed to form ethylene then oxidation of the ethanol to ethylene oxide: vaporization of an ethanol feed and at least a portion of a flow of diluting water comprising recycled ethanol so as to produce a vaporized feed, compression in a compressor driven by a condensing turbine driven by the steam generated by an oxidation step, dehydration of a mixture of compressed vaporized feed, separation of effluent obtained from dehydration into ethylene and water, purification of at least a portion of effluent containing water and separation into at least a flow of treated water and a flow of diluting water containing ethanol, recycling the latter upstream of the vaporization, oxidation of ethylene containing in the effluent into ethylene oxide, in at least one tubular oxidation reactor cooled by vaporization of a quench flow, said vaporized quench flow being used to drive a condensing turbine. | 2015-12-24 |
20150368216 | SINGLE STEP PROCESS FOR CONVERSION OF FURFURAL TO TETRAHYDROFURAN - The present patent discloses a one step process for the synthesis of THF and related ring hydrogenated products form furfural using Palladium metal based carbon supported catalyst with high selectivity and 100% conversion in both batch and continuous modes. | 2015-12-24 |
20150368217 | Derivative of Homoserine Lactone, and Preparation Method and Use Thereof - A derivative of homoserine lactone represented by formula I, and a preparation method and use thereof. The compound has a bacterial quorum-sensing regulatory effect, and can be used for prevention and/or treatment of a disease caused by a bacterial infection. | 2015-12-24 |
20150368218 | OXIDATION OF ALCOHOL COMPOUNDS VIA MESOSTRUCTURED VPO CATALYSTS - The present invention concerns a process for the production of an aldehyde compound by an oxidation reaction of an alcohol compound in the presence of a mesostructured vanadium phosphorus mixed oxide catalyst, at a temperature comprised between 50° C. and 200° C., in presence of an oxidant. The reaction medium may also comprise a solvent. | 2015-12-24 |
20150368219 | Process for Purifying Crude Furan 2,5-Dicarboxylic Acid Using Hydrogenation - A process to produce a dry purified furan-2,5-dicarboxylic acid (FDCA) is described. After oxidation of 5-(hydroxymethyl)furfural (5-HMF), a crude FDCA stream is produced that is fed to a crystallization zone followed by a solid-liquid displacement zone to form a low impurity slurry stream. The solids in the low impurity slurry stream are dissolved in a dissolution zone to produce a hydrogenation feed that is hydrogenated in a hydrogenation reactor to generate a hydrogenated FDCA composition. The hydrogenated FDCA composition is routed to a crystallization zone to form a crystallized produce stream that is separated from liquid in a solid-liquid separation zone to generate a purified wet cake stream containing FDCA that can be dried in a drying zone to generate a dry purified FDCA product stream. | 2015-12-24 |
20150368221 | CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS - The present invention provides compounds of formula (I) or a pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein W, X, n, s, t, and Ra are as described herein. The present invention relates generally to selective inhibitors of histone deacetylase and to methods of making and using them. | 2015-12-24 |
20150368222 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS - The present invention provides calcium sensing receptor modulators (CaSR). In particular, the compounds described herein are useful for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of calcium sensing receptors (CaSR). The invention also provides herein the pharmaceutical compositions thereof, and methods for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of CaSR. The invention also relates to process for the preparation of the compounds of the invention. | 2015-12-24 |
20150368223 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS - A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or−) epicatechin echm and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-protected quercetin obtained from step (i); (iii) optionally deprotecting the compound of step (ii); (iv) reducing the compound obtained from step (ii) or step (iii) in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; (v) deprotecting and/or hydrogenation of the chiral intermediate obtained from step (iv) to obtain (−)-epicatechin; (vi) optionally simultaneously deprotecting and by drogenation of the compound obtained from step (ii) to obtain racemic epicatechin. | 2015-12-24 |
20150368224 | NOVEL ALLYL COMPOUND AND METHOD FOR PRODUCING THE SAME - The allyl compound of the present invention is represented by general formula (α): | 2015-12-24 |
20150368225 | 1,3-DIOXANE COMPOUND HAVING FLUORINE ATOM IN AXIAL POSITION, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE - A liquid-crystal compound satisfying at least one physical property such as a high clearing point, large dielectric anisotropy and excellent compatibility with other liquid-crystal compounds is described; a liquid-crystal composition containing the compound; and a liquid-crystal display device. | 2015-12-24 |
20150368226 | PIPERIDINYLCARBAZOLES - The present invention provides compounds of Formula (I) for the treatment of parasitic diseases including malaria, as well as neurodegenerative diseases. Formula (I) wherein R | 2015-12-24 |
20150368227 | PROCESS FOR THE PREPARATION OF POLYMORPHS OF IMIDACLOPRID - A process for the preparation of a Form I crystalline polymorph of imidacloprid, including: (i) dissolving imidacloprid in an appropriate amount of aqueous solvent or mixture of solvents to obtain an aqueous solution; (ii) cooling the aqueous solution slowly, thereby forming crystals of polymorph Form I of imidacloprid; (iii) isolating the crystals. A process for the preparation of a Form II crystalline polymorph of imidacloprid, comprising: dissolving imidacloprid in an appropriate amount of non-aqueous solvent or mixture of non-aqueous solvents to obtain a non-aqueous solution; (ii) cooling the solution rapidly, thereby forming crystals of polymorph Form II of imidacloprid; (iii) isolating the crystals | 2015-12-24 |
20150368228 | ANTIVIRAL COMPOUNDS - The present invention discloses compounds of Formula (I): wherein the variables in Formula (I) are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula (I) in the prevention or treatment of HCV infection. | 2015-12-24 |
20150368229 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF - Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein. | 2015-12-24 |
20150368230 | RADIOLABELED QUINAZOLINE DERIVATIVES - Novel radiotracer for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging are described. Specifically, the invention relates to | 2015-12-24 |
20150368231 | N-SUBSTITUTED-5-SUBSTITUTED PHTHALAMIC ACIDS AS SORTILIN INHIBITORS - The present invention is directed to N-substituted-5-substituted phthalamic acids which of formula (A). The compounds are considered useful for the treatment of diseases treatment of a neurodegenerative disease, psychiatric disease, motorneuron disease, peripheral neuropathies, pain, neuroinflammation or atherosclerosis such as Alzheimer's disease and Parkinson's disease. | 2015-12-24 |